about
Lipid phosphate phosphatase (LPP3) and vascular developmentMelanoma cells break down LPA to establish local gradients that drive chemotactic dispersalStructural evidence of the species-dependent albumin binding of the modified cyclic phosphatidic acid with cytotoxic properties2D binary QSAR modeling of LPA3 receptor antagonism.Improved method for the quantification of lysophospholipids including enol ether species by liquid chromatography-tandem mass spectrometry.Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acidEndocannabinoids and diacylglycerol kinase activity.Ligand-based autotaxin pharmacophore models reflect structure-based docking results.Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effectCalcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunctionAutotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs.Structure-based drug design identifies novel LPA3 antagonists.Unlocking the biology of RAGE in diabetic microvascular complicationsUnique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.Lysophosphatidic Acid signals through specific lysophosphatidic Acid receptor subtypes to control key regenerative responses of human gingival and periodontal ligament fibroblasts.
P2860
Q27002640-608FE190-1939-42D2-A49A-5C152FC9A00DQ27313853-7DFD67D7-1D95-4175-A9DD-02EF1B385AF7Q27704759-A1B7B763-77E5-4A14-8030-69C51ED26091Q33548210-20F38927-580A-46F8-9F9E-AC3E0637EEE4Q33577898-6A2EF1E6-95C5-4713-9D01-BC351AB641F4Q34580111-6E7B9940-8F28-48AD-B1FC-A3E24DC35532Q34696352-A187D7C9-9DF1-4061-8D14-D3A78A3705ABQ35575527-AC53022D-97CC-4959-A808-48A0C4AFA431Q36452780-1ED5D793-073A-4EF6-89A7-30B25A6ADA29Q37194251-8F10D187-11DB-47A7-AADC-1AB433C89102Q37199186-89D0AE1E-6090-49FC-A0DB-C3122CF09BABQ37250907-BB340E04-FB3B-4BD2-8479-A7AFCD7A73B9Q37407372-AF22A0A4-EF62-4020-99CB-0B5279F209DDQ38134924-23550166-7E85-4D0B-9E27-CB880397E397Q39987593-DC8BF418-CD03-4369-B782-93BB8E36BC46Q43298340-DF7F2B08-D0C5-4E01-8040-132D853BF852
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Lysophospholipid interactions with protein targets.
@en
type
label
Lysophospholipid interactions with protein targets.
@en
prefLabel
Lysophospholipid interactions with protein targets.
@en
P2860
P1476
Lysophospholipid interactions with protein targets.
@en
P2093
Abby L Parrill
P2860
P304
P356
10.1016/J.BBALIP.2008.04.011
P407
P577
2008-05-02T00:00:00Z